Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association

Authors: Nauman A Jadoon, Mohammad A Shahzad, Rehan Yaqoob, Mansoor Hussain, Naseema Ali

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

There is a growing body of literature on the relationship of Hepatitis C virus infection (HCV) and type 2 diabetes mellitus (T2DM). However, there are certain gaps in literature and the data is inconclusive. This study was, therefore, carried out to determine the prevalence of HCV infection in diabetic patients and to elucidate the presence of any possible relationship between HCV and T2DM in this region.

Methods

Serologic testing for anti-HCV antibody was done on a sample of 3000 individuals with T2DM visiting Diabetes Clinic of Nishtar Medical College Hospital, Multan and 10,000 volunteer blood donors visiting blood bank of the same hospital during the study period using Accurate rapid immunochromatographic kits which was later confirmed by using Chemelex S.A third generation ELISA kit for positive cases. Data about various variables was collected from diabetic patients using a structured questionnaire after taking informed consent.

Results

Prevalence rate of 13.7% for HCV infection was recorded among subjects having T2DM with seropositivity rate of 4.9% among the control group of volunteer blood donors without diabetes. The patients with T2DM were more likely to have HCV infection as compared to the control group (OR = 3.03, 95%CI = 2.64-3.48, p = 0.001). Diabetic patients with age above 55 years had higher prevalence rate as compared to younger individuals. Male patients had significantly high seropositivity as compared to female patients (15.3% vs. 12.4%, p = 0.02). Those with duration of diabetes 11 years and above and the ones with good glycemic control had higher seroprevalence rates of 18.2% and 18.7% respectively. There was no statistically significant difference among subjects when the distribution of HCV was studied on the basis of marital status, locality, or family history of diabetes.

Conclusions

The results show that there is a strong association between HCV and T2DM in the region as evident from significantly higher prevalence of HCV infection in diabetics as compared to the control group in the present study.
Literature
1.
go back to reference NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 2002,19(3):1-46. NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 2002,19(3):1-46.
2.
go back to reference Kumar V, Abbas AK, Fausto N, Aster J, eds: Robbins and Cotran Pathologic Basis of Disease. 8th edition. China: Elsevier; 2010. Kumar V, Abbas AK, Fausto N, Aster J, eds: Robbins and Cotran Pathologic Basis of Disease. 8th edition. China: Elsevier; 2010.
3.
go back to reference Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds: Harrison's Principles of Internal Medicine. 17th edition. New York: McGraw-Hill Professional; 2008. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds: Harrison's Principles of Internal Medicine. 17th edition. New York: McGraw-Hill Professional; 2008.
4.
go back to reference Asselah T, Rubbia-Brandt L, Marcellin P, Negro F: Steatosis in chronic hepatitis C: why does it really matter? Gut 2006, 55: 123-130. 10.1136/gut.2005.069757PubMedPubMedCentralCrossRef Asselah T, Rubbia-Brandt L, Marcellin P, Negro F: Steatosis in chronic hepatitis C: why does it really matter? Gut 2006, 55: 123-130. 10.1136/gut.2005.069757PubMedPubMedCentralCrossRef
5.
go back to reference Andreone P, Gramenzi A, Cursaro C, Benardi M, Zignego AL: Monoclonal gammopathy in patients with chronic hepatitis C virus infection. Blood 1996, 88: 1122.PubMed Andreone P, Gramenzi A, Cursaro C, Benardi M, Zignego AL: Monoclonal gammopathy in patients with chronic hepatitis C virus infection. Blood 1996, 88: 1122.PubMed
6.
go back to reference Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB: Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007, 39: 2-17. 10.1016/j.dld.2006.06.008PubMedCrossRef Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB: Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007, 39: 2-17. 10.1016/j.dld.2006.06.008PubMedCrossRef
7.
go back to reference White DL, Ratziu V, El-Serag HB: Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008, 49: 831-844. 10.1016/j.jhep.2008.08.006PubMedPubMedCentralCrossRef White DL, Ratziu V, El-Serag HB: Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008, 49: 831-844. 10.1016/j.jhep.2008.08.006PubMedPubMedCentralCrossRef
8.
go back to reference Allison ME, Wreghitt T, Palmer CR, Alexander GJ: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994, 21: 1135-1139. 10.1016/S0168-8278(05)80631-2PubMedCrossRef Allison ME, Wreghitt T, Palmer CR, Alexander GJ: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994, 21: 1135-1139. 10.1016/S0168-8278(05)80631-2PubMedCrossRef
9.
go back to reference Simo R, Hernandez C, Genesca J, Jardi R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19: 998-1000. 10.2337/diacare.19.9.998PubMedCrossRef Simo R, Hernandez C, Genesca J, Jardi R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19: 998-1000. 10.2337/diacare.19.9.998PubMedCrossRef
10.
go back to reference Rudoni S, Petit JM, Bour JB, Aho LS, Castaneda A, Vaillant G, Verges B, Brun JM: HCV infection and diabetes mellitus: influence of the use of finger stick devices on nosocomial transmission. Diabetes Metab 1999, 25: 502-505.PubMed Rudoni S, Petit JM, Bour JB, Aho LS, Castaneda A, Vaillant G, Verges B, Brun JM: HCV infection and diabetes mellitus: influence of the use of finger stick devices on nosocomial transmission. Diabetes Metab 1999, 25: 502-505.PubMed
11.
go back to reference Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29: 328-333. 10.1002/hep.510290235PubMedCrossRef Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29: 328-333. 10.1002/hep.510290235PubMedCrossRef
12.
go back to reference Qureshi H, Ahsan T, Mujeeb SA, Jawad F, Mehdi I, Ahmed W, Alam SE: Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J Pak Med Assoc 2002, 52: 280-283.PubMed Qureshi H, Ahsan T, Mujeeb SA, Jawad F, Mehdi I, Ahmed W, Alam SE: Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J Pak Med Assoc 2002, 52: 280-283.PubMed
13.
go back to reference Okan V, Araz M, Aktaran S, Karsligil T, Meram I, Bayraktaroglu Z, Demirci F: Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract 2002, 56: 175-177.PubMed Okan V, Araz M, Aktaran S, Karsligil T, Meram I, Bayraktaroglu Z, Demirci F: Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract 2002, 56: 175-177.PubMed
14.
go back to reference Chen HF, Li CY, Chen P, See TT, Lee HY: Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006, 69: 146-152. 10.1016/S1726-4901(09)70195-9PubMedCrossRef Chen HF, Li CY, Chen P, See TT, Lee HY: Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006, 69: 146-152. 10.1016/S1726-4901(09)70195-9PubMedCrossRef
15.
go back to reference Picerno I, Di Pietro A, Spataro P, Di Benedetto A, Romano G, Scoglio ME: Is diabetes mellitus a risk factor for HCV infection? Ann Ig 2002, 14: 473-477.PubMed Picerno I, Di Pietro A, Spataro P, Di Benedetto A, Romano G, Scoglio ME: Is diabetes mellitus a risk factor for HCV infection? Ann Ig 2002, 14: 473-477.PubMed
16.
go back to reference Balogun WO, Adeleye JO, Akinlade KS, Kuti M, Otegbayo JA: Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital. J Natl Med Assoc 2006, 98: 1805-1808.PubMedPubMedCentral Balogun WO, Adeleye JO, Akinlade KS, Kuti M, Otegbayo JA: Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital. J Natl Med Assoc 2006, 98: 1805-1808.PubMedPubMedCentral
17.
go back to reference Gulcan A, Gulcan E, Toker A, Bulut I, Akcan Y: Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J Investig Med 2008, 56: 858-863.PubMed Gulcan A, Gulcan E, Toker A, Bulut I, Akcan Y: Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J Investig Med 2008, 56: 858-863.PubMed
18.
go back to reference Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Herrmann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH: Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-a. Eur J Clin Invest 2000,30(2):111-121. 10.1046/j.1365-2362.2000.00608.xPubMedCrossRef Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Herrmann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH: Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-a. Eur J Clin Invest 2000,30(2):111-121. 10.1046/j.1365-2362.2000.00608.xPubMedCrossRef
19.
go back to reference Petit JM, Bour JM, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P: Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. Hepatology 2001, 35: 279-283. 10.1016/S0168-8278(01)00143-XCrossRef Petit JM, Bour JM, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P: Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. Hepatology 2001, 35: 279-283. 10.1016/S0168-8278(01)00143-XCrossRef
20.
go back to reference Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY: Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol 2003, 9: 505-8.PubMedPubMedCentralCrossRef Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY: Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol 2003, 9: 505-8.PubMedPubMedCentralCrossRef
21.
go back to reference Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology 2001, 33: 1554. 10.1053/jhep.2001.0103306le01PubMedCrossRef Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology 2001, 33: 1554. 10.1053/jhep.2001.0103306le01PubMedCrossRef
22.
go back to reference Hamid S, Umar M, Alam A, Siddiqui A, Qureshi H, Butt J, Pakistan Society of Gastroenterology: PSG consensus statement on management of hepatitis C virus infection--2003. J Pak Med Assoc 2004,54(3):146-50.PubMed Hamid S, Umar M, Alam A, Siddiqui A, Qureshi H, Butt J, Pakistan Society of Gastroenterology: PSG consensus statement on management of hepatitis C virus infection--2003. J Pak Med Assoc 2004,54(3):146-50.PubMed
23.
go back to reference Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010,87(1):4-14. 10.1016/j.diabres.2009.10.007PubMedCrossRef Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010,87(1):4-14. 10.1016/j.diabres.2009.10.007PubMedCrossRef
25.
go back to reference Ndako JA, Echeonwu GO, Shidali NN, Bichi IA, Paul GA, Onovoh E, Okeke LA: Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria. Virol J 2009, 6: 98. 10.1186/1743-422X-6-98PubMedPubMedCentralCrossRef Ndako JA, Echeonwu GO, Shidali NN, Bichi IA, Paul GA, Onovoh E, Okeke LA: Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria. Virol J 2009, 6: 98. 10.1186/1743-422X-6-98PubMedPubMedCentralCrossRef
26.
go back to reference Parolin MB, Réa R, Vargas RM, de Almeida AC, Baldanzi GR, Lopes RW: [Prevalence of hepatitis C infection in patients with type 2 diabetes mellitus]. Article in Portuguese. Arq Gastroenterol 2006,43(2):77-80. 10.1590/S0004-28032006000200003PubMedCrossRef Parolin MB, Réa R, Vargas RM, de Almeida AC, Baldanzi GR, Lopes RW: [Prevalence of hepatitis C infection in patients with type 2 diabetes mellitus]. Article in Portuguese. Arq Gastroenterol 2006,43(2):77-80. 10.1590/S0004-28032006000200003PubMedCrossRef
27.
go back to reference Li-Ng M, Tropp S, Danoff A, Bini EJ: Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis 2007, 39: 549-556. 10.1016/j.dld.2007.02.014PubMedCrossRef Li-Ng M, Tropp S, Danoff A, Bini EJ: Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis 2007, 39: 549-556. 10.1016/j.dld.2007.02.014PubMedCrossRef
28.
go back to reference Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL: Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003, 38: 50-56. 10.1053/jhep.2003.50291PubMedCrossRef Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL: Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003, 38: 50-56. 10.1053/jhep.2003.50291PubMedCrossRef
29.
go back to reference Kaabia N, Ben Jazia E, Slim I, Fodha I, Hachfi W, Gaha R, Khalifa M, Hadj Kilani A, Trabelsi H, Abdelaziz A, Bahri F, Letaief A: Association of hepatitis C virus infection and diabetes in central Tunisia. World J Gastroenterol 2009,15(22):2778-2781. 10.3748/wjg.15.2778PubMedPubMedCentralCrossRef Kaabia N, Ben Jazia E, Slim I, Fodha I, Hachfi W, Gaha R, Khalifa M, Hadj Kilani A, Trabelsi H, Abdelaziz A, Bahri F, Letaief A: Association of hepatitis C virus infection and diabetes in central Tunisia. World J Gastroenterol 2009,15(22):2778-2781. 10.3748/wjg.15.2778PubMedPubMedCentralCrossRef
30.
go back to reference Costa LM, Mussi AD, Brianeze MR, Souto FJ: Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Braz J Infect Dis 2008, 12: 24-26.PubMedCrossRef Costa LM, Mussi AD, Brianeze MR, Souto FJ: Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Braz J Infect Dis 2008, 12: 24-26.PubMedCrossRef
31.
go back to reference Ali SS, Ali IS, Aamir AH, Jadoon Z, Inayatullah S: Frequency of hepatitis C infection in diabetic patients. J Ayub Med Coll Abbottabad 2007,19(1):46-9.PubMed Ali SS, Ali IS, Aamir AH, Jadoon Z, Inayatullah S: Frequency of hepatitis C infection in diabetic patients. J Ayub Med Coll Abbottabad 2007,19(1):46-9.PubMed
32.
go back to reference Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O'Rahilly S, Shore S, Tom BD, Alexander GJ: Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30: 1059-1063. 10.1002/hep.510300416PubMedCrossRef Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O'Rahilly S, Shore S, Tom BD, Alexander GJ: Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30: 1059-1063. 10.1002/hep.510300416PubMedCrossRef
Metadata
Title
Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association
Authors
Nauman A Jadoon
Mohammad A Shahzad
Rehan Yaqoob
Mansoor Hussain
Naseema Ali
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-304

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue